It seems that resazurin-based viability assays (such as Alamar Blue) are frequently used with hepatocytes or hepatic cell lines cultures, but the effect of resaruzin on the induction of cytochroms P450 on the samples is barely discussed. As these tests are usually non-destructive, it is appealing to use the same sample for the viability assay then CYP induction analysis, but I can't find an actual proof that resazurin won't affect the CYP activity. Does anyone have feedback or insight on this question? Thanks a lot!

More Timothée Baudequin's questions See All
Similar questions and discussions